1:19cv4183 • May 8, 2019
Class Period Start
January 4, 2019
Class Period End
April 30, 2019
PSLRA Deadline
July 8, 2019
Case Allegations
10b5
Statutes of Repose
Jan 4, 2022
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
April 30, 2021
Settlement Fund
$3,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that PURCHASED OR OTHERWISE ACQUIRED NABRIVA THERAPEUTICS PLC’S (“NABRIVA”) COMMON STOCK DURING THE PERIOD FROM JANUARY 4, 2019, THROUGH APRIL 30, 2019, BOTH DATES INCLUSIVE.
Claim Administrator
A.B. Data, Ltd.
Nabriva Securities Litigation
Settlement Administrator
c/o A.B. Data, Ltd. P.O. Box 173091
Milwaukee, WI 53217
+1 800-918-9014
[email protected]
Settlement Website
-Hearing Date
May 14, 2021
Opt-out Deadline
April 30, 2021
Settlement Note
Download hereProof Of Claim
Download here
May 23, 2022
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
May 14, 2021
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Feb 18, 2021
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Jan 28, 2021
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Aug 21, 2020
Aug 11, 2020
Aug 4, 2020
Jun 24, 2020
A new complaint has been filed on behalf of certain investors in Nabriva Therapeutics plc. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Jun 23, 2020
Sep 20, 2019
A new complaint has been filed on behalf of certain investors in Nabriva Therapeutics plc. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Aug 13, 2019
Aug 1, 2019
Jul 22, 2019
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
May 8, 2019
A securities fraud class action complaint has been filed on behalf of certain investors in Nabriva Therapeutics plc.
TOP
